
BNTX
Healthcare · Biotechnology · $21.22B market cap
$85.60+0.56 (+0.7%)Nov 13, 4:26 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -123.1% over 90 days · 30-day revisions 0 up, 4 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 3, 2026 | Before the open | 0.85 | 1.94 | +128.2% |
| Aug 4, 2026 | Before the open | -2.58 | -3.03 | -17.4% |
| May 5, 2026 | Before the open | -1.92 | -1.95 | -1.6% |
| Mar 10, 2026 | Time not confirmed | -0.25 | -0.33 | -33.5% |
| Nov 3, 2025 | Before the open | 0.10 | -0.12 | -220.0% |
| Aug 4, 2025 | Before the open | -1.41 | -1.60 | -13.5% |
| May 5, 2025 | Before the open | -2.35 | -1.73 | +26.4% |
| Mar 10, 2025 | Time not confirmed | 0.48 | 1.08 | +126.6% |
| Nov 4, 2024 | Before the open | -1.61 | 0.81 | +150.3% |
| Aug 5, 2024 | Before the open | -2.04 | -3.36 | -64.7% |
| May 6, 2024 | Before the open | -1.17 | -1.41 | -20.5% |
| Mar 20, 2024 | Before the open | 2.42 | 1.90 | -21.5% |
| Nov 6, 2023 | Before the open | -0.67 |
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative…
| 0.67 |
| +200.0% |
| Aug 7, 2023 | Before the open | -0.73 | -0.79 | -8.2% |
| May 8, 2023 | Before the open | 0.52 | 2.05 | +294.2% |
| Mar 27, 2023 | Before the open | 7.99 | 9.26 | +15.9% |
| Nov 7, 2022 | Before the open | 3.42 | 6.98 | +104.1% |
| Aug 8, 2022 | Before the open | 7.08 | 6.45 | -8.9% |
| May 9, 2022 | Before the open | 9.16 | 14.24 | +55.5% |
| Mar 30, 2022 | Before the open | 7.44 | 12.18 | +63.7% |
| Nov 9, 2021 | Before the open | 10.54 | 12.35 | +17.2% |
| Aug 9, 2021 | Before the open | 7.55 | 10.77 | +42.6% |
| May 10, 2021 | Before the open | 3.64 | 4.39 | +20.6% |
| Mar 30, 2021 | Before the open | -0.15 | 1.57 | +1146.7% |
| Nov 10, 2020 | Before the open | -0.40 | -0.88 | -120.0% |
| Aug 11, 2020 | After the close | -0.32 | -0.38 | -18.8% |
| May 12, 2020 | After the close | -0.24 | -0.24 | 0.0% |
| Mar 31, 2020 | Before the open | -0.17 | -0.26 | -52.9% |
| Nov 14, 2019 | Before the open | -0.17 | -0.14 | +17.6% |